Moderator: 3ne2nr Mods
st7 wrote:https://www.nytimes.com/2021/11/16/health/covid-pill-pfizer.html
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries
bigpharma at it again
redmanjp wrote:st7 wrote:https://www.nytimes.com/2021/11/16/health/covid-pill-pfizer.html
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries
bigpharma at it again
can u post the article? keep getting a paywall block
Pfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor Countries
Nov. 16, 2021, at 11:15 a.m.
By Robert Preidt and Robin Foster, HealthDay Reporter
(HEALTHDAY)
TUESDAY, Nov. 16, 2021 (HealthDay News) -- Pfizer Inc. announced Tuesday that it has reached an agreement for its promising COVID-19 antiviral pill to be made and sold cheaply in 95 developing nations.
The countries included in the licensing deal are mostly in Africa and Asia, and they account for more than half of the world's population, the company said in a statement. Pfizer is partnering on the agreement with Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to lifesaving drugs for low- and middle-income countries.
Under the terms of the deal, Pfizer will grant a royalty-free license for the pill to MPP and manufacturers can then take out a sublicense. They will receive Pfizer's formula for the drug, and be able to sell it for use in 95 developing countries after regulators authorize the drug in those places.
"Pfizer remains committed to bringing forth scientific breakthroughs to help end this pandemic for all people. We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections, decreasing the strain on our health care systems and saving lives," Pfizer chairman and CEO Albert Bourla said in the statement. "We must work to ensure that all people – regardless of where they live or their circumstances – have access to these breakthroughs."
Last month, Merck reached a similar deal for its COVID-19 antiviral pill to be made and sold inexpensively in 105 poorer countries.
"The fact that we now have two manufacturer-anywhere licenses for these two drugs is a big change, and it draws a big contrast with the restrictive licensing so far for vaccines," James Love, head of Knowledge Ecology International, a nonprofit that researches access to medical products, told The New York Times.
"This license is so important because, if authorized or approved, this oral drug is particularly well-suited for low- and middle-income countries and could play a critical role in saving lives, contributing to global efforts to fight the current pandemic," MPP executive director Charles Gore said in the Pfizer statement.
However, both the Pfizer and Merck agreements exclude a number of low- and middle-income nations that have been hit hard by the pandemic, including Brazil, China, Cuba, Iraq, Jamaica, Libya and Russia.
paid_influencer wrote:I still can't understand why people who need the third shot can't just walk into a mass vaxx site and get it.
redmanjp wrote:https://www.usnews.com/news/health-news/articles/2021-11-16/pfizer-covid-pill-to-be-made-sold-cheaply-in-95-poor-countriesPfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor Countries
Nov. 16, 2021, at 11:15 a.m.
By Robert Preidt and Robin Foster, HealthDay Reporter
(HEALTHDAY)
TUESDAY, Nov. 16, 2021 (HealthDay News) -- Pfizer Inc. announced Tuesday that it has reached an agreement for its promising COVID-19 antiviral pill to be made and sold cheaply in 95 developing nations.
The countries included in the licensing deal are mostly in Africa and Asia, and they account for more than half of the world's population, the company said in a statement. Pfizer is partnering on the agreement with Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to lifesaving drugs for low- and middle-income countries.
Under the terms of the deal, Pfizer will grant a royalty-free license for the pill to MPP and manufacturers can then take out a sublicense. They will receive Pfizer's formula for the drug, and be able to sell it for use in 95 developing countries after regulators authorize the drug in those places.
"Pfizer remains committed to bringing forth scientific breakthroughs to help end this pandemic for all people. We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections, decreasing the strain on our health care systems and saving lives," Pfizer chairman and CEO Albert Bourla said in the statement. "We must work to ensure that all people – regardless of where they live or their circumstances – have access to these breakthroughs."
Last month, Merck reached a similar deal for its COVID-19 antiviral pill to be made and sold inexpensively in 105 poorer countries.
"The fact that we now have two manufacturer-anywhere licenses for these two drugs is a big change, and it draws a big contrast with the restrictive licensing so far for vaccines," James Love, head of Knowledge Ecology International, a nonprofit that researches access to medical products, told The New York Times.
"This license is so important because, if authorized or approved, this oral drug is particularly well-suited for low- and middle-income countries and could play a critical role in saving lives, contributing to global efforts to fight the current pandemic," MPP executive director Charles Gore said in the Pfizer statement.
However, both the Pfizer and Merck agreements exclude a number of low- and middle-income nations that have been hit hard by the pandemic, including Brazil, China, Cuba, Iraq, Jamaica, Libya and Russia.
pugboy wrote:old ppl rush the stadium early today for pfizer and it ran out
timelapse wrote:I had 2 sino shots, what are the acceptable options for the third?
pugboy wrote:old ppl rush the stadium early today for pfizer and it ran out
redmanjp wrote:pugboy wrote:old ppl rush the stadium early today for pfizer and it ran out
These are for boosters?
redmanjp wrote:pugboy wrote:old ppl rush the stadium early today for pfizer and it ran out
These are for boosters?
pugboy wrote:old ppl rush the stadium early today for pfizer and it ran out
WHO Interim statement on COVID-19 vaccination for children and adolescents
24 November 2021
https://www.who.int/news/item/24-11-202 ... dolescents
FrankChag wrote:If I'm reading this correctly, the MOH can self-determine if children 5-11 can now be vaccinated?
(Based on the fact that adult vaccination has stagnated).WHO Interim statement on COVID-19 vaccination for children and adolescents
24 November 2021
https://www.who.int/news/item/24-11-202 ... dolescents
Duane 3NE 2NR wrote:FrankChag wrote:If I'm reading this correctly, the MOH can self-determine if children 5-11 can now be vaccinated?
(Based on the fact that adult vaccination has stagnated).WHO Interim statement on COVID-19 vaccination for children and adolescents
24 November 2021
https://www.who.int/news/item/24-11-202 ... dolescents
The dosage of the Pfizer for ages 5-11 is different.
The vial colour is different also
Pfizer CEO says fourth Covid vaccine doses may be needed sooner than expected due to omicron
Published Wed, Dec 8 202112:06 PM EST
Key Points
-“When we see real-world data, will determine if the omicron is well covered by the third dose and for how long,” Pfizer CEO Albert Bourla told CNBC.
-“And the second point, I think we will need a fourth dose,” Bourla said.
-The Pfizer CEO originally expected a fourth dose 12 months after the third, but he told CNBC it might be needed faster than that.